HIF1A and breast neoplasm: Interestingly, this opposes results found in human monocyte-derived macrophages (MDMs) which found HIF-1α bound preferentially in promoters while HIF-2α binding was more pronounced in enhancer regions, suggesting that breast tumor cells may not adequately reflect HIFα binding preferences in macrophages [47].